Table 2

Comparison of the clinical characteristics of the children with shock and the other critically ill patients who received postpyloric nutrition

Shock

Other patients

p


Number of patients

65

461

Age (months) (median, range)

12 (0.7–264)

5 (0.1–228)

.020

Weight (kg) (median, range)

8.8 (2.5–70)

5.3 (2.1–70)

.0001

Sex (male/female)

44/21 (2.1/1)

248/213 (1.1/1)

.045

Cardiac surgery

44 (67.7%)

330 (71.6%)

.559

Dopamine (median, range)

62 (95.4%)

10 (3–50)

307 (66.6%)

5 (0.5–20)

.0001

.0001

Adrenaline (median, range)

49 (75.4%)

0.3 (0.02–5)

71 (15.4%)

0.2 (0.04–0.3)

.0001

.001

Milrinone (median, range)

45 (69.2%)

0.7 (0.4–0.8)

206 (44.7%)

0.5 (0.5–1)

.0001

.246

Acute renal failure

26 (40%)

27 (5.9%)

.0001

Hepatic disturbances

3 (4.8%)

6 (1.3%)

.081

Nosocomial pneumonia

9 (15.5%)

38 (8.9%)

.152

Mortality

18 (27.7%)

32 (6.9%)

.0001

Midazolam (median, range)

64 (98.5%)

7 (2–16)

384 (83.3%)

4 (0.5–20)

.0001

.0001

Fentanyl (median, range)

64 (98.5%)

6.5 (1–14)

366 (79.4%)

4 (1–25)

.0001

.0001

Vecuronium (median, range)

51 (78.5%)

0.1 (0.1–0.25)

179 (38.8%)

0.1 (0.1–0.3)

.0001

.660


Maximum dose of drugs during nutrition. Units: mcg/kg/min (dopamine, adrenaline, milrinone, midazolam); mcg/kg/h (fentanyl, vecuronium)

López-Herce et al. Nutrition Journal 2008 7:6   doi:10.1186/1475-2891-7-6

Open Data